- Citations, last 5 years
- 2 490
- Works, last 5 years
- 440
- h-index
- 112
- Scientists listed
- 28
- Grants since 2016
- 3 213
Grants received
2021–2026 · program · P50
Core 2: Biospecimen
Elisa De Stanchina · Kettering University · funded by National Institutes of Health
2021–2026 · program · P50
Core 3: Biostatistics
Mithat Gonen · Kettering University · funded by National Institutes of Health
2021–2026 · program · P50
Career Enhancement Program
Omar Abdel-Wahab · Kettering University · funded by National Institutes of Health
2021–2026 · program · P50
Administrative Core
Omar Abdel-Wahab · Kettering University · funded by National Institutes of Health
2021–2026 · program · P50
Project 1: Increasing therapeutic efficacy in isocitrate dehydrongenase (IDH)–mutant acute myeloid leukemia (AML)
Ross L Levine · Kettering University · funded by National Institutes of Health
2021–2026 · program · P50
Core 1: Genomics
Elli Papaemmanuil · Kettering University · funded by National Institutes of Health
2021–2026 · program · P50
Project 4: Chimeric Antigen Receptor T Cell Therapy for the Treatment of Acute Myeloid Leukemia
Renier Joseph Brentjens · Kettering University · funded by National Institutes of Health
2021–2026 · program · P50
Core 3: Biostatistics
Mithat Gonen · Kettering University · funded by National Institutes of Health
2021–2026 · program · P50
Career Enhancement Program
Omar Abdel-Wahab · Kettering University · funded by National Institutes of Health
2021–2026 · program · P50
Core 1: Genomics
Elli Papaemmanuil · Kettering University · funded by National Institutes of Health
2021–2026 · program · P50
Developmental Research Program
Ross L Levine · Kettering University · funded by National Institutes of Health
2021–2026 · program · P50
Project 4: Chimeric Antigen Receptor T Cell Therapy for the Treatment of Acute Myeloid Leukemia
Renier Joseph Brentjens · Kettering University · funded by National Institutes of Health
2021–2026 · program · P50
Project 3: Therapeutic inhibition of splicing through inhibition of protein arginine methylation in leukemia
Omar Abdel-Wahab · Kettering University · funded by National Institutes of Health
2021–2026 · program · P50
Developmental Research Program
Ross L Levine · Kettering University · funded by National Institutes of Health
2021–2026 · program · P50
Project 3: Therapeutic inhibition of splicing through inhibition of protein arginine methylation in leukemia
Omar Abdel-Wahab · Kettering University · funded by National Institutes of Health
2021–2026 · program · P50
Core 2: Biospecimen
Elisa De Stanchina · Kettering University · funded by National Institutes of Health
2021–2026 · program · P50
Administrative Core
Omar Abdel-Wahab · Kettering University · funded by National Institutes of Health
2020 · research · R01
Implications and Vulnerabilities of APOBEC Mutagenesis in Breast Cancer
Sarat Chandarlapaty · Kettering University · funded by National Institutes of Health
2020–2023 · research · R21
Communicating with Oncology Nurses about Values from the Outset (CONVO): An Innovative Primary Palliative Care Intervention in English and Espanol
Francesca M Gany · Kettering University · funded by National Institutes of Health
2020–2024 · research · R01
Determining the risk factor profile and biology of colorectal cancer in Nigeria
Olusegun Isaac Alatise · Kettering University · funded by National Institutes of Health
2020–2025 · research · R01
Toward development of senolytic CAR T cells
Scott W. Lowe · Kettering University · funded by National Institutes of Health
2020–2023 · research · R03
Neural and Cognitive Mechanisms of Attention and Memory Deficits in Cancer Survivors
James C Root · Kettering University · funded by National Institutes of Health
2020–2025 · research · R01
Leveraging fructose transport to create a privileged substrate to selectively fuel T cells
Kayvan R Keshari · Kettering University · funded by National Institutes of Health
2020–2025 · career development · K08
Local blockade of IL10R on innate immune cells to mediate both innate and adaptive anti-tumor immunity
Danny Khalil · Kettering University · funded by National Institutes of Health
2020–2024 · research · R01
Rapid and flexible precision oncology mouse models of epithelial malignancies epithelial malignancies
Scott W. Lowe · Kettering University · funded by National Institutes of Health
2020–2026 · career development · K08
Local blockade of IL10R on innate immune cells to mediate both innate and adaptive anti-tumor immunity
Danny Khalil · Kettering University · funded by National Institutes of Health
2020–2025 · research · R35
Investigating histone glycation as a new dynamic epigenetic mark
Yael E David-Shternberg · Kettering University · funded by National Institutes of Health
2020–2025 · cooperative agreement · U01
Prospective Trial of a Linguistically and Culturally Appropriate Mainstreaming Model for Hereditary Cancer Multigene Panel Testing Among Diverse Cancer Patients
Jada Gabrielle Hamilton · Kettering University · funded by National Institutes of Health
2020–2025 · research · R37
Regulation of tumor suppression by alpha-ketoglutarate
Lydia Finley · Kettering University · funded by National Institutes of Health
2020–2025 · career development · K08
Local blockade of IL10R on innate immune cells to mediate both innate and adaptive anti-tumor immunity
Danny Khalil · Kettering University · funded by National Institutes of Health
2020–2025 · cooperative agreement · U01
Comparative Modeling of Effective Policies for Colorectal Cancer Control
Amy Knudsen · Kettering University · funded by National Institutes of Health
2020–2025 · cooperative agreement · U01
Evaluation of the effect of patient-context factors and sample acquisition on the quality and analytical performance of cell-free DNA and circulating tumor cells profiling assays in prostate cancer pa
Maria E Arcila · Kettering University · funded by National Institutes of Health
2020–2024 · research · R01
Development and validation of an intraoperative imaging agent for the peripheral nervous system
Thomas Reiner · Kettering University · funded by National Institutes of Health
2020–2025 · cooperative agreement · U01
A Statistical Physics Framework for Understanding the Role of Repeat RNA in Tumor Immunity
Benjamin Greenbaum · Kettering University · funded by National Institutes of Health
2020–2025 · research · R01
Dose de-escalation of HPV-associated oropharynx cancers: Exploration of HPV mediated radiation sensitivity
Nancy Y Lee · Kettering University · funded by National Institutes of Health
2020–2023 · research · R13
Approaches to Curtail Endometrial Cancer Incidence and Mortality
Michele L. Cote · Kettering University · funded by National Institutes of Health
2020–2022 · career development · K08
Dissecting the Roles and Requirements for RBM39 in Acute Myeloid Leukemia and Normal Hematopoiesis
Sydney X Lu · Kettering University · funded by National Institutes of Health
2020–2023 · cooperative agreement · UE5
MSK Immuno-Oncology for the Translational Researcher Short Course
Ushma Neill · Kettering University · funded by National Institutes of Health
2020–2025 · research · R01
A Randomized Controlled Trial of Emotion Regulation Therapy for Cancer Caregivers: A Mechanism-Targeted Approach to Addressing Caregiver Distress
Allison Applebaum · Kettering University · funded by National Institutes of Health
2020–2025 · research · R37
Acupuncture for Chemothrapy-induced Peripheral Neuropathy Treatment (ACT)Trial
Ting Bao · Kettering University · funded by National Institutes of Health